サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1375084

北米の医療用経皮吸収パッチ市場の2028年までの予測-地域別分析-タイプ別、用途別、流通チャネル別

North America Transdermal Medical Patch Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and Distribution Channel
出版日: | 発行: The Insight Partners | ページ情報: 英文 143 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
北米の医療用経皮吸収パッチ市場の2028年までの予測-地域別分析-タイプ別、用途別、流通チャネル別
出版日: 2023年08月21日
発行: The Insight Partners
ページ情報: 英文 143 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の医療用経皮吸収パッチ市場は、2023年の34億9,863万米ドルから2028年には43億2,469万米ドルに成長すると予測されています。2023年から2028年までのCAGRは4.3%と推定されます。

タバコ消費の増加が北米医療用経皮吸収パッチ市場を促進

米国では、タバコは疾病、障害、死亡の重大な原因の一つです。CDCが2021年に発表したデータによると、米国では推定2,830万人の成人がタバコを吸っています。米国では毎日1,600人近く（18歳未満）が初めてタバコを吸い、50万人近くの米国人が副流煙にさらされて早死にします。同じソースによると、電子タバコは中高生の間で最も頻繁に使用されているタバコ製品です。CDCはまた、米国は成人の喫煙関連疾患の治療に毎年2,250億米ドル以上を医療費に費やしているとしています。

ニコチン置換療法（NRT）は、禁煙を目指す人々を助けることが証明されています。NRTは、ニコチンパッチを使用し、適度な量のニコチンを投与することで、禁煙欲求を和らげるものです。ニコチンパッチを貼ると、ニコチンは徐々に皮膚から吸収されます。依存度の高い喫煙者は最も強力なパッチを使用し、依存度の低い喫煙者はより少ない投与量を使用することができます。急性NRT製剤（ガム、鼻腔スプレー、経口吸入器、錠剤）に対するニコチン・パッチの決定的な利点は、一日中薬を消費するのではなく、コンプライアンスが簡単なことです。

したがって、タバコの消費の増加はニコチンパッチの需要の増加につながり、経皮医療パッチ市場の成長を促進します。

北米の医療用経皮吸収パッチ市場概要

北米の医療用経皮吸収パッチ市場は米国、カナダ、メキシコに区分されます。2022年、北米の医療用経皮吸収パッチ市場で最大のシェアを占めたのは米国でした。慢性疾患を患う患者数の増加と研究開発の主な発展が医療用経皮吸収パッチ市場を推進している主な要因です。

北米の医療用経皮吸収パッチ市場の収益と2028年までの予測（金額）

北米の医療用経皮吸収パッチ市場のセグメンテーション

北米の医療用経皮吸収パッチ市場は、タイプ、用途、流通チャネル、国に区分されます。

タイプ別では、単層薬剤接着剤、多層薬剤接着剤、リザーバー、蒸気パッチ、マトリックスに区分されます。2023年にはマトリックスセグメントが最大の市場シェアを記録しました。

用途別では、神経疾患、疼痛管理、ニコチン禁煙、心血管障害、ホルモン療法、その他に区分されます。疼痛管理分野が2023年に最大の市場シェアを占めました。

流通チャネルに基づき、北米の医療用経皮吸収パッチ市場は病院薬局、小売薬局、オンライン薬局に区分されます。病院薬局セグメントが2023年に最大の市場シェアを占めました。

国別では、北米の医療用経皮吸収パッチ市場は米国、カナダ、メキシコに区分されます。米国が2023年の市場シェアを独占しました。

Boehringer Ingelheim International GmbH、Corium, LLC、Endo International Inc、久光製薬株式会社、Johnsons and Johnsons、Medline Industries LP、Novartis AG、Teva Pharmaceutical Industries Ltd.、UCB SA、Viatris Incが、この地域の医療用経皮吸収パッチ市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 医療用経皮吸収パッチ市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の医療用経皮吸収パッチ市場-市場情勢

  • 概観
  • PEST分析
    • 北米のPEST分析
  • 専門家の見解

第5章 医療用経皮吸収パッチの北米市場：主要市場力学

  • 市場促進要因
    • 慢性疾患の有病率の増加
    • タバコ消費の増加
  • 市場抑制要因
    • 薬剤の不具合による医療用経皮吸収パッチのリコール
  • 市場機会
    • 戦略的イニシアチブの増加
  • 今後の動向
    • スマートパッチと3Dプリントパッチの進歩
  • 影響分析

第6章 医療用経皮吸収パッチ市場：北米分析

  • 北米の医療用経皮吸収パッチ市場の収益予測と分析

第7章 北米の医療用経皮吸収パッチ市場：タイプ別収益と2028年までの予測

  • イントロダクション
  • 医療用経皮吸収パッチ市場のタイプ別収益シェア（2022年、2028年）
  • 単層型薬物接着剤
  • 多層薬物接着剤
  • リザーバー
  • 蒸気パッチ
  • マトリックス

第8章 北米の医療用経皮吸収パッチ市場：用途別収益と2028年までの予測

  • イントロダクション
  • 医療用経皮吸収パッチ市場の用途別売上高シェア（2022年、2028年）
  • 神経疾患
  • 疼痛管理
  • ニコチン停止
  • 心血管疾患
  • ホルモン療法
  • その他

第9章 北米の医療用経皮吸収パッチ市場：販売チャネル別収益と2028年までの予測

  • イントロダクション
  • 医療用経皮吸収パッチ市場の流通チャネル別収益シェア（2022年、2028年）
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 医療用経皮吸収パッチ市場：2028年までの収益と予測：国別分析

  • 北米

第11章 業界情勢

  • イントロダクション
  • 成長戦略
  • 概要

第12章 企業プロファイル

  • Hisamitsu Pharmaceutical Co Inc
  • Medline Industries LP
  • Johnson & Johnson
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • UCB SA
  • Viatris Inc
  • Endo Pharmaceuticals Inc
  • Boehringer Ingelheim International GmbH
  • Corium, LLC.

第13章 付録

図表

List Of Tables

  • Table 1. US Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. US Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 3. US Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Canada Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Canada Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Canada Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Mexico Transdermal Medical Patch Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Mexico Transdermal Medical Patch Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Mexico Transdermal Medical Patch Market, by Distribution Channels - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Recent Growth Strategies in Transdermal Medical Patch Market
  • Table 11. Glossary of Terms

List Of Figures

  • Figure 1. Transdermal Medical Patch Market Segmentation
  • Figure 2. Transdermal Medical Patch Market by Region
  • Figure 3. North America Transdermal Medical Patch Market Overview
  • Figure 4. Matrix is The Largest Share of Type Segment in North America Transdermal Medical Patch Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. North America Experts' Opinion
  • Figure 8. North America Transdermal Medical Patch Market Impact Analysis of Drivers and Restraints
  • Figure 9. North America Transdermal Medical Patch Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
  • Figure 11. Single-Layer Drug In-Adhesive: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Multi-Layer Drug In-Adhesive: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Reservoir: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Vapor Patch: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Matrix: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. North America Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
  • Figure 17. Neurologic Conditions: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Pain Management: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Nicotine Cessation: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Cardiovascular Disorders: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Hormonal Therapy: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Others: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. North America Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022 and 2028)
  • Figure 24. Hospital Pharmacies: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Retail Pharmacies: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Online Pharmacies: North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. North America: Transdermal Medical Patch Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 28. North America: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
  • Figure 29. US: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Canada: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Mexico: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028759

The North America transdermal medical patch market is expected to grow from US$ 3,498.63 million in 2023 to US$ 4,324.69 million by 2028. It is estimated to register a CAGR of 4.3% from 2023 to 2028.

Growing Consumption of Tobacco Fuels North America Transdermal Medical Patch Market

In the US, tobacco is one of the significant causes of disease, disability, and death. According to the data published by CDC in 2021, an estimated 28.3 million adults smoke cigarettes in the US. Nearly 1,600 people (younger than 18 years) smoke their first cigarette every day in the US, and nearly half a million Americans die prematurely due to secondhand smoke exposure. As per the same source, e-cigarettes are the most frequently used tobacco products among high and middle school students. CDC also states that the US spends more than US$ 225 billion on medical care each year to treat smoking-related diseases in adults.

Nicotine replacement therapy (NRT) has proven to help people seeking to quit smoking. It makes use of nicotine patches that deliver modest nicotine dosages to relieve cravings. Nicotine is progressively absorbed through the skin once nicotine patches are applied. Smokers with a greater dependence level can use the most robust patches, while those with a lower dependence level can use a lesser dosage. The critical advantage of nicotine patches over acute NRT formulations (gum, nasal spray, oral inhaler, and tablet) is the simplicity of compliance, rather than consuming a medicine throughout the day.

Thus, the increasing consumption of tobacco leads to increasing demand for nicotine patches, thereby driving the growth of the transdermal medical patch market.

North America Transdermal Medical Patch Market Overview

The North American transdermal medical patch market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America transdermal medical patch market. The rising number of patients suffering from chronic conditions and increasing activities in research and development are the key factors propelling the market for transdermal medical patches.

North America Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)

North America Transdermal Medical Patch Market Segmentation

The North America transdermal medical patch market is segmented into type, application, distribution channel, and country.

Based on type, the market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch, and matrix. The matrix segment registered the largest market share in 2023.

Based on application, the market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment held the largest market share in 2023.

Based on distribution channel, the North America transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.

Based on country, the North America transdermal medical patch market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.

Boehringer Ingelheim International GmbH, Corium, LLC, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America transdermal medical patch market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America transdermal medical patch market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the transdermal medical patch market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Transdermal Medical Patch Market - by Type
    • 1.3.2 North America Transdermal Medical Patch Market - by Application
    • 1.3.3 North America Transdermal Medical Patch Market - by Distribution Channel
    • 1.3.4 North America Transdermal Medical Patch Market - by Country

2. Transdermal Medical Patch Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Transdermal Medical Patch Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 Expert's Opinion

5. North America Transdermal Medical Patch Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Growing Consumption of Tobacco
  • 5.2 Market Restraints
    • 5.2.1 Recalls of Transdermal Medical Patches due to Drug Failure
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Strategic Initiatives
  • 5.4 Future Trends
    • 5.4.1 Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches
  • 5.5 Impact analysis

6. Transdermal Medical Patch Market - North America Analysis

  • 6.1 North America Transdermal Medical Patch Market Revenue Forecast and Analysis

7. North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Type

  • 7.1 Overview
  • 7.2 Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
  • 7.3 Single-Layer Drug In-Adhesive
    • 7.3.1 Overview
    • 7.3.2 Single-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Multi-Layer Drug In-Adhesive
    • 7.4.1 Overview
    • 7.4.2 Multi-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Reservoir
    • 7.5.1 Overview
    • 7.5.2 Reservoir: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Vapor Patch
    • 7.6.1 Overview
    • 7.6.2 Vapor Patch: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Matrix
    • 7.7.1 Overview
    • 7.7.2 Matrix: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Application

  • 8.1 Overview
  • 8.2 Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
  • 8.3 Neurologic Conditions
    • 8.3.1 Overview
    • 8.3.2 Neurologic Conditions: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Pain Management
    • 8.4.1 Overview
    • 8.4.2 Pain Management: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Nicotine Cessation
    • 8.5.1 Overview
    • 8.5.2 Nicotine Cessation: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Cardiovascular Disorders
    • 8.6.1 Overview
    • 8.6.2 Cardiovascular Disorders: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Hormonal Therapy
    • 8.7.1 Overview
    • 8.7.2 Hormonal Therapy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Distribution Channels

  • 9.1 Overview
  • 9.2 Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022and 2028)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Retail Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Online Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)

10. Transdermal Medical Patch Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 North America: Transdermal Medical Patch Market
    • 10.1.1 The Overview
    • 10.1.2 North America: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
      • 10.1.2.1 US: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 US: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.3 US: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.1.4 US: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.1.5 US: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.2 Canada: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Canada: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.3 Canada: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.2.4 Canada: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.2.5 Canada: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
      • 10.1.2.3 Mexico: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Mexico: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.3 Mexico: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
        • 10.1.2.3.4 Mexico: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
        • 10.1.2.3.5 Mexico: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Hisamitsu Pharmaceutical Co Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medline Industries LP
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Johnson & Johnson
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Novartis AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Teva Pharmaceutical Industries Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 UCB SA
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Viatris Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Endo Pharmaceuticals Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Boehringer Ingelheim International GmbH
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Corium, LLC.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms